Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Tumor, Adult 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 28 Radiotherapy 20 pembrolizumab 9 Paclitaxel 9 Surveys and Questionnaires 8 Cetuximab 8 Fluorouracil 7 Docetaxel 7 Radiotherapy, Intensity-Modulated 6 Carboplatin 6 apatinib 5 Low-Level Light Therapy 5 Blood Specimen Collection 5 durvalumab 4 Standard of Care 4 Magnetic Resonance Imaging 4 Gemcitabine 4 Cyclophosphamide 4 Celecoxib 4 Tegafur 3 Radiation 3 Oncolytic Virotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lidocaine 3 Immunoenzyme Techniques 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Biopsy 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × Digoxin × Clear all

NCT02906800 2017-10-19

DIGHANC

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡